UNITED HEALTH PRODUCTS INC TO HOST DIAL IN CORPORATE UPDATE

Henderson, NV -  October 11, 2016 - United Health Products, Inc. (OTCQB: UEEC) will hold a dial in conference for shareholders, potential shareholders and those seeking to learn more about the company on October 13, 2016. Douglas Beplate CEO and Louis Schiliro Director of Manufacturing will discuss the company’s current events and expansion of manufacturing capacities to meet the increase in current orders in the dental, veterinary, medical and retail markets. Management will also report on the future plans and efforts of the company to uplist to a higher exchange. The call in conference will be Thursday October 13th at 12:30 pm Eastern. To listen to the discussion:

Participant Instructions: 

1.  Call your Dial-In Number: (712) 451-0011 
2.  Enter your Access Code: 291859.

Anyone not able to access or attend the call can go to the company’s website www.unitedhealthproductsinc.com and listen to the entire call which will posted as an audio file on Friday October 14th by noon EST.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444



United Health Products Inc. Announces Optimal Government Services Has Completed Their Distribution Agreement and Placed Stocking Orders

Henderson, NV -  May 16, 2016 - United Health Products, Inc. (OTCQB: UEEC) announced that Optimal Government Resources has signed their distribution agreement and placed an opening stocking order. In conjunction with this agreement, UHP HemoStyp® products are now listed under the DAPA contract #SP0200-09-H-0037. This begins an exciting new chapter for United Health Products and allows all US military, US government agencies and VA systems to order directly or via their Prime Vendor agreements.

About Optimal Government Services

Optimal GS is a participant in the Department of Defense (DOD) and Department of Veterans Affairs Medical/Surgical Prime Vendor Programs (MSPV), and the DOD and VA Pharmaceutical Prime Vendor Program (PPV). Optimal has commercial agreements with the National and Regional Prime Vendors to ensure highly efficient national distribution of its products to its Federal Customer Base. This customer base includes the DOD, all branches of the military, all federal government offices and programs. Optimal GS specializes in distribution of medical products through this network, utilizing the MSPV bridge contracts. The VA has created a major benefit to our Nation's Veterans by continuing to provide efficient and unparalleled medical supply support to VA medical centers nationwide. The program is mandatory for all VA medical centers. The MSPV program includes McKesson and Cardinal distribution.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

United Health Products Inc. Announces Optimal Government Services Has Completed Their Distribution Agreement and Placed Stocking Orders

Henderson, NV -  May 16, 2016 - United Health Products, Inc. (OTCQB: UEEC) announced that Optimal Government Resources has signed their distribution agreement and placed an opening stocking order. In conjunction with this agreement, UHP HemoStyp® products are now listed under the DAPA contract #SP0200-09-H-0037. This begins an exciting new chapter for United Health Products and allows all US military, US government agencies and VA systems to order directly or via their Prime Vendor agreements.

About Optimal Government Services

Optimal GS is a participant in the Department of Defense (DOD) and Department of Veterans Affairs Medical/Surgical Prime Vendor Programs (MSPV), and the DOD and VA Pharmaceutical Prime Vendor Program (PPV). Optimal has commercial agreements with the National and Regional Prime Vendors to ensure highly efficient national distribution of its products to its Federal Customer Base. This customer base includes the DOD, all branches of the military, all federal government offices and programs. Optimal GS specializes in distribution of medical products through this network, utilizing the MSPV bridge contracts. The VA has created a major benefit to our Nation's Veterans by continuing to provide efficient and unparalleled medical supply support to VA medical centers nationwide. The program is mandatory for all VA medical centers. The MSPV program includes McKesson and Cardinal distribution.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

United Health Products Announces Henry Schein Halas as Exclusive Distributor

Henderson, NV -  May 2, 2016 - United Health Products, Inc. (OTCQB: UEEC)) announced that they have signed Henry Schein Halas to an exclusive distribution agreement for all of United Health’s HemoStyp® products in conjunction with an initial stocking order for Australia and the African Continent. Henry Schein Halas was formed in 2006, when two of Australia's most innovative and successful dental businesses joined together. Built on decades of service to the profession by Halas Dental Ltd and Henry Schein Regional Ltd, the company maintains strong Australian management together with the commitment and investment of Henry Schein, the world's leading dental distributor. Their commitment to meeting and exceeding the service expectations of our customers is deeply ingrained in to their organization.  Henry Schein currently supplies over 80% of all dental practices in Australia and New Zealand and has 18 distribution centers in the region. Henry Schein is also the number one supplier in Australia and New Zealand in the Veterinary market. Henry Schein currently supplies more than 70% of the market.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444



United Health Products Announces Henry Schein Halas as Exclusive Distributor

Henderson, NV -  May 2, 2016 - United Health Products, Inc. (OTCQB: UEEC)) announced that they have signed Henry Schein Halas to an exclusive distribution agreement for all of United Health’s HemoStyp® products in conjunction with an initial stocking order for Australia and the African Continent. Henry Schein Halas was formed in 2006, when two of Australia's most innovative and successful dental businesses joined together. Built on decades of service to the profession by Halas Dental Ltd and Henry Schein Regional Ltd, the company maintains strong Australian management together with the commitment and investment of Henry Schein, the world's leading dental distributor. Their commitment to meeting and exceeding the service expectations of our customers is deeply ingrained in to their organization.  Henry Schein currently supplies over 80% of all dental practices in Australia and New Zealand and has 18 distribution centers in the region. Henry Schein is also the number one supplier in Australia and New Zealand in the Veterinary market. Henry Schein currently supplies more than 70% of the market.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444



United Health Products Inc. Announces Exclusive Distributor for India

Henderson, NV -  March 9, 2016 - United Health Products, Inc. (OTCQB: UEEC)) announced that it has entered into an exclusive distribution contract with CJ Global Capital LLC for India. The exclusive contract has a licensing fee and minimum yearly purchase requirements to maintain the rights to exclusivity to India for all of United Health Products Inc. HemoStyp® products. India's current health care industry is estimated to be USD 120 Billion and reach USD 230 Billion by 2020, with USD 5.5 Billion in Wound Care. Indian Government Expenditure on health care is the highest amongst all the developing countries. The expenses of this industry comprise 5.25% of the GDP. India is the second most populous country in the world, with over 1.277 billion people (2015), more than a sixth of the world's population. 

About CJ Global Capital LLC

CJ Global Capital LLC is a private international investment group headquartered in the United States specializing in projects involving patented products, new technologies, and large scale commercial real estate development. CJGC sales and marketing efforts for wholesaling will be led by David Champion, Marketing Director of Asia Pacific for Apollo RT Co., Ltd. Apollo RT Co. is a new Japanese owned company with manufacturing in China. David Champion is responsible for marketing and strategy for the Asian Market. In addition, David is Country Director for Apollo RT Co. business in Korea and Canada. David lived in India in the late 1990's and was employed by a company which is now part of GE Healthcare. He worked 13 years for Tyco Healthcare (later known as Covidien) in urological products (including incontinence products) and wound care products. CJGC various projects total USD 1 billion.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

 


United Health Products Announces Optimal Government Services as Exclusive Government Distributor

Henderson, NV -  January 21, 2016 - United Health Products, Inc. (OTCQB: UEEC)) announced that it has entered into a contract with Optimal Government Resources as the exclusive government distributor for its HemoStyp® product line.  Douglas Beplate, CEO of United Health Products Inc. added, “We are very pleased to be working with Optimal GS and to provide our HemoStyp® products to the U.S. Military and other U.S. Government agencies”.  The contract outlines the addition of HemoStyp® products to Optimal’s ERP, Service Order Module, included in the existing DAPA MS contract, registered in the Military and DOD Prime Vendor catalogs and assigned number registry with the Prime Vendor.

About Optimal Government Services

Optimal GS is a participant in the Department of Defense and Department of Veterans Affairs Medical/Surgical Prime Vendor Programs (MSPV), and the DOD and VA Pharmaceutical Prime Vendor Program (PPV). Optimal has commercial agreements with the National and Regional Prime Vendors to ensure highly efficient national distribution of its products to its Federal Customer Base. Optimal GS specializes in moving medical product through this network.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

 


United Health Products Inc. HemoStyp® Now Available From Patterson Veterinary

Henderson, NV -  November 19, 2015 - United Health Products, Inc. (OTCQB: UEEC)) announced that one of the nation's largest veterinary distribution companies Patterson Veterinary, a leading supplier of health supplies and equipment to veterinarians, has placed their initial stocking order with AMD Ritmed www.amdritmed.com, United Health's Sales and Marketing partner. Patterson Veterinary will be distributing and promoting the HemoStyp® products nationwide. Patterson Veterinary distributes consumable veterinary supplies, equipment, software, diagnostic products, vaccines and pharmaceuticals to veterinary clinics throughout the U.S. and U.K. Douglas Beplate CEO of United Health Products Inc. added, "We are very pleased to be working with Patterson Veterinary to provide HemoStyp® to clinics and Veterinarians across the country. Hemostyp® is the perfect product for providing faster bleeding control in small and large animals".

About Patterson Animal Health

Patterson is a Fortune 1000 member recognized by Forbes as one of America's Most Trusted Companies. Patterson's business presence includes the animal health and dental markets. The Company employs approximately 7,000 team members in North America and the U.K.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

 


United Health Products Inc. HemoStyp® Now Available Through Henry Schein

Henderson, NV -  August 24, 2015 - United Health Products, Inc. (OTCQB: UEEC)) developer, manufacturer and marketer of patented hemostatic gauze for the dental, healthcare, veterinary and wound care sectors, today announced that Henry Schein, the nation’s largest distributor of dental products,  is now providing HemoStyp® to Dental professionals across the country. Hemostyp® is now available to all dental professionals nationwide through Henry Schein www.henryschein.com and its vast network.

About Henry Schein, Inc

Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 25 countries. For more information, visit the Henry Schein Web site at www.henryschein.com. 

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

 


United Health Products Inc. Announces ‘School Health’ as a Distributor

Henderson, NV -  August 24, 2015 - United Health Products, Inc. (OTCQB: UEEC)) announced that School Health, the nation's leading supplier of health supplies and equipment to schools, has placed their initial stocking order with UEEC and will be distributing and promoting the HemoStyp® products nationwide. HemoStyp® will be featured in a fall back to school promotion. School Health supplies over 60,000 schools across the country. School Health has evolved from a specialized distributor of basic supplies to a consultative solutions provider for major health initiatives including vision and hearing screening, emergency response preparedness, infection control, and wellness plans. 

In addition, they own and operate Sports Health, a division of School Health that provides products for the sports medicine arena. Douglas Beplate, CEO of United Health Products Inc., added, "We are very pleased to be working within the School Health network and to provide our HemoStyp® to school nurses, sports team trainers, security staff, and emergency personnel throughout the nation to address trauma and wound incidents."

About School Health

School Health Corporation (www.schoolhealth.com) is the leading supplier of health supplies and equipment to schools. More than 95% of the top 500 school districts and largest universities in the United States purchase their products from the company annually. School Health offers customers more than 20,000 products from over 600 manufacturers. This third-generation, family-owned, business was founded in 1957 and currently employs more than 100 people.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

For Investor Relations:
PCG Advisory Group, LLC
Kirin Smith, Managing Director
+1-646-863-6519
ksmith@pcgadvisory.com
www.pcgadvisory.com

For Media Relations:
Sean Leous, Managing Director 
+1 646.863-8998

United Health Products Engages Maxim Group LLC As Corporate Finance Advisor

Henderson, NV -  July 21, 2015 - United Health Products, Inc. (OTCQB: UEEC) developer, manufacturer and marketer of patented hemostatic gauze for the dental, healthcare, veterinary and wound care sectors, today announced  that the Company has engaged Maxim Group LLC, as its new corporate finance advisor.  Maxim Group, a leading full-service investment bank, securities and wealth management firm, will assist the Company in determining near term growth strategies to execute their business plan. 

Douglas Beplate, Chief Executive Officer of United Health Products, commented, “We are excited to begin working with Maxim.  They have assembled a solid team of knowledgeable and experienced industry professionals that we believe will be critical in moving the Company forward in its mission to develop quality, user-friendly and reliable products for the wound care and retail  markets.  As our Company continues to evolve, having a partner like Maxim Group will help us expand our business and deliver on our overall strategic plan.”

About Maxim Group LLC

Maxim Group LLC is a leading full-service investment banking, securities and wealth management firm headquartered in New York.  The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed income and derivative sales & trading, equity research and prime brokerage services to a diverse range of corporate clients, institutional investors and high net worth individuals.  Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission and the Municipal Securities Rulemaking Board (MSRB), and is a member of the following: Financial Industry Regulatory Authority (FINRA), Securities Insurance Protection Corporation (SIPC), NASDAQ Stock Market and NYSE Arca, Inc.  To learn more about Maxim Group, visit www.maximgrp.com.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

For Investor Relations:
PCG Advisory Group, LLC
Kirin Smith, Managing Director
+1-646-863-6519
ksmith@pcgadvisory.com
www.pcgadvisory.com

For Media Relations:
Sean Leous, Managing Director 
+1 646.863-8998


United Health Products Inc. Announces Laboratory Test Results

Henderson, NV -  April 7, 2015 - United Health Products, Inc. (OTCQB: UEEC) has received the final laboratory test results and pathology reports for recent porcine testing. The laboratory tests were performed at Mount Sterling Laboratories, and the autopsy and pathology performed at the Utah Veterinary Diagnostic Laboratory, Utah State University.

The test protocol was designed to determine the length of time required to achieve hemostasis on a lateral femoral artery cut in pigs. Hemostasis is a process which causes bleeding to stop. As part of the protocol, the HemoStyp® gauze was placed on the wound site and upon achieving hemostasis, the product was left on the wound site without any sutures, bands, clamps, etc. The wound site was then closed with another strip of HemoStyp® that was placed just under the skin

.Complete hemostasis was achieved within 25 minutes on the incision of the femoral artery. Upon completion of the test, with the HemoStyp® gauze remaining in the cavity, the pigs were placed in an enclosure and allowed to recover. Ten hours after the procedures, two of the three pigs were up and walking, the third pig did not naturally recover. The two pigs were penned and monitored for three weeks eating and gaining weight as they resumed an active life. After three weeks, the pigs were euthanized and autopsied.

The autopsy results determined that there was no trace of HemoStyp® product or residue of the product in the body or any of the organs. Douglas Beplate, CEO said, "The results are remarkable in that they not only show that HemoStyp® is effective at rapid hemostasis in a wound site, but prove it is totally absorbable into the body." He added, "In my opinion HemoStyp® promotes vascular genesis and healing."

The tests reports were furnished to the U.S. Military will be posted for viewing on the United Health Products Inc. website.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

PCG Advisory Group, LLC
Kirin Smith, Managing Director
+1-646-863-6519
ksmith@pcgadvisory.com
www.pcgadvisory.com

Media Contact:
Sean Leous
Chief Communications Officer
PCG Advisory Group
D: 646.863-8998
www.pcgadvisory.com


United Health Products Inc. Announces Total Resources International as Specialty - Retail Distributor

Henderson, NV -  March 17, 2015 - United Health Products, Inc. (OTCQB: UEEC)) announced that it has entered into a 5 year contract with Total Resources International (TRI) as a United States Specialty and Retail Distributor. The contract guarantees minimum purchases of United Health Products Inc.'s HemoStyp® products with yearly increases over the previous year. The contract calls for 150,000 trauma pads, 500,000 boxes of HemoStrips® and an exclusive distribution of UHP's HemoStrip® with metal detectable fabric for the food industry that can be easily detected if the strip were to fall off during processing or preparation. Sales generated from this contract are a minimum of three million dollars for year 1 and expected to gross over 20 million dollars in sales during the life of the contract. 

About TRI

TRI began as a small family owned business in 1991 and has since grown over 17 times to become one of the leading manufacturers of first aid and emergency survival products. TRI is located in Los Angeles County California that conducts operations on a 7 acre site with 5 Buildings totaling over 120,000 sq. feet. TRI clients include Walmart, Sam's Club, Target, Walgreens, Nissan and Hyundai to name a few. TRI's management team brings experienced professionals in the areas of Marketing, Design, Information Systems, Production and Executive Management. TRI has been providing product to the country's top retailers for over 20 years. TRI's mission is to be the most dependable and innovative manufacture of First Aid Kits and Emergency Preparedness kits in all categories of Home, Office, School, Auto, Sporting goods, Outdoors, Marina and Farm for the purpose of spreading the Good News and supporting Ministries and Missionaries of all nations.
www.totalresourcesintl.com

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444



United Health Products Inc. Announces Total Resources International as Specialty - Retail Distributor

Henderson, NV -  March 17, 2015 - United Health Products, Inc. (OTCQB: UEEC)) announced that it has entered into a 5 year contract with Total Resources International (TRI) as a United States Specialty and Retail Distributor. The contract guarantees minimum purchases of United Health Products Inc.'s HemoStyp® products with yearly increases over the previous year. The contract calls for 150,000 trauma pads, 500,000 boxes of HemoStrips® and an exclusive distribution of UHP's HemoStrip® with metal detectable fabric for the food industry that can be easily detected if the strip were to fall off during processing or preparation. Sales generated from this contract are a minimum of three million dollars for year 1 and expected to gross over 20 million dollars in sales during the life of the contract. 

About TRI

TRI began as a small family owned business in 1991 and has since grown over 17 times to become one of the leading manufacturers of first aid and emergency survival products. TRI is located in Los Angeles County California that conducts operations on a 7 acre site with 5 Buildings totaling over 120,000 sq. feet. TRI clients include Walmart, Sam's Club, Target, Walgreens, Nissan and Hyundai to name a few. TRI's management team brings experienced professionals in the areas of Marketing, Design, Information Systems, Production and Executive Management. TRI has been providing product to the country's top retailers for over 20 years. TRI's mission is to be the most dependable and innovative manufacture of First Aid Kits and Emergency Preparedness kits in all categories of Home, Office, School, Auto, Sporting goods, Outdoors, Marina and Farm for the purpose of spreading the Good News and supporting Ministries and Missionaries of all nations.
www.totalresourcesintl.com

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444



United Health Products Inc. to Increase National Presence with Experienced Distributor Sales Force

Henderson, NV -  January 28, 2015 - United Health Products, Inc. (OTCQB: UEEC) announced that AMD-Ritmed the Company's distributor for the U.S., has added 30 additional salespeople. This, experienced, dedicated sales force will begin selling United Health Product's proprietary line of HemoStyp® gauze products as well as AMD products to the various healthcare and medical markets. United Health Products Inc. conducted an educational and servicing forum for the new sales staff in St. Louis Mo. The 30 plus new sales representatives will immediately begin to call on accounts nationwide. It is anticipated they will be reaching out to hundreds of end users and distributors over the next 60 days.

UHPs CEO Douglas Beplate commented, "This is a major step forward to introduce and validate our HemoStyp® product to various sectors of the health care industry. This validation will only enhance the opportunities in our future endeavors as we create national brand and product awareness."

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

About AMD - Ritmed
For over 30 years, AMD-Ritmed has been a leading manufacturer of surgical dressings and related products as well as distributor of products utilized in hospitals and healthcare facilities. AMD-Ritmed has evolved into a multinational manufacturer and distributor of wound care, personal protection, general medical, and surgical supplies. For more on AMD-Ritmed visit: www.amdritmed.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

PCG Advisory Group, LLC
Kirin Smith, Managing Director
+1-646-863-6519
ksmith@pcgadvisory.com
www.pcgadvisory.com


United Health Products Reports Highly Significant Test Results for HemoStyp®

Henderson, NV -  January 20, 2015 - United Health Products, Inc. (OTCQB: UEEC) announced that it has received formal results of recent tests performed at Spring Valley Laboratories, a GLP compliant CRO laboratory. These tests were performed on pigs that had their femoral arteries exposed. A 5 millimeter puncture wound was established and the arterial tissue removed, creating a hole in the femoral artery. The arterial bleeding was allowed for a 45 second interval prior to any HemoStyp® gauze being applied under constant pressure. Fluid was administered to the pig through a catheter placed in the neck to replace any blood loss through the wound site. The administered fluids consisting of .9 % sterile crystalloid fluids further diluted the blood and created extreme pressure at the wound site.

The test on the non-control pigs began with examining how much material was best administrated to control arterial bleeding. The first two subjects showed that HemoStyp® was far more effective when using less material than first assumed. Once the effective amount was determined, two subjects achieved successful hemostasis in an average time of 36 minutes. In accordance with test protocol, the subjects were monitored for up to 180 minutes to substantiate baseline vitals were achieved and maintained. The next closest competitive product tested in a similar manner demonstrated an average time of hemostasis in 63 minutes.

Douglas Beplate, CEO of United Health Products, commented, "We feel these results are remarkable because we were repeatedly, demonstrating and achieving complete hemostasis in a significantly faster time than products that were previously tested. More importantly, we were able to achieve this milestone with an all-natural, absorbable product. Management intends to incorporate these findings to further improve usage protocols and promote our products for their demonstrated superior benefits." 

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

PCG Advisory Group, LLC
Sean Leous, Managing Director
+1-646-683-8998
sleous@pcgadvisory.com
www.pcgadvisory.com


United Health Products Inc. to Launch HemoStrip™ Adhesive Bandage to Retail Market

Henderson, NV -  January 15, 2015 - United Health Products, Inc. (OTCQB: UEEC) announced that it has initiated introduction of its HemoStrip™ line of hemostatic adhesive bandages to major retailers. HemoStrip™ adhesive bandages utilize United Health Products (UHP) patented HemoStyp® Hemostatic Gauze and are available in a variety of sizes. The addition of a hemostatic pad gives HemoStrip™ an advantage over ordinary adhesive bandages which simply absorb blood. The hemostatic material interacts instantly with blood to significantly reduce clotting times and promote healing.

It is estimated that approximately 70% of US households purchase bandages. The US market consists of 115 million households with estimated annual sales of $3 billion.

UHP is concentrating its initial retail efforts on major pharmacy and grocery chains. Initial presentations of HemoStrip™ have been received positively. Packaging and labeling parameters are being addressed and new packaging sent for approval. UHP is confident that retailer orders can be fulfilled within 30 - 45 days upon receipt of a purchase order.

Douglas Beplate, CEO United Health Products, commented, "This is a very exciting time for our Company and our proprietary products. The initial reaction from retailers has been encouraging and we are quickly moving forward. We are optimistic that HemoStrip™ will play an important role in allowing us to meet our retail projections for 2015 of an estimated 5 million dollars."

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

PCG Advisory Group, LLC
Kirin Smith, Managing Director
+1-646-863-6519
ksmith@pcgadvisory.com
www.pcgadvisory.com


United Health Products Announces Australian Sales Update

Henderson, NV -  December 17, 2014 - United Health Products, Inc. (OTCQB: UEEC) announced today that the Company has received an additional stocking order for the HemoStyp® gauze products from its Australian distributor, Critical Health Products Pty Ltd. and distribution partner for Australia, Westcoast Surgical & Medical Supplies for 2014. Critical Health Products has also secured future purchase orders for 2015 in excess of $ US 250,000 with expectations of over $ US 500,000.  

After a pause in operations due to a pending lawsuit that has been settled and recorded in the State of Nevada in October of 2014, the Company has commenced full operations and production. The settlement included the cancellation of notes owed by the Company totaling over $ US 500,000 and the return of approximately 1 million shares of the common stock of the Company to treasury. 

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

PCG Advisory Group, LLC
Scott Powell, Managing Director
Tel: +1-646-780-8850
Email: spowell@pcgadvisory.com
www.pcgadvisory.com


United Health Products Announces Current Positive State of Events Positive Product News Better Positions the Company for Global Growth

Henderson, NV – December 11, 2014 – United Health Products Inc. (OTCQB: UEEC) today released a corporate summary pertaining to recent Company events.

Distribution of the Company's Products

Last week United Health Products attended a series of corporate meetings with AMD-Ritmed and Medicom in Montreal, Canada. AMD-Ritmed and Medicom are the exclusive distributors of the HemoStyp® product line in the US and Canada. Scott Wolford, Vice President of AMD-Ritmed, was excited to announce the addition of sales and marketing resources to promote the HemoStyp® product lines.

Critical Health and its distribution partner in Australia, Western Surgical, announced that they have entered into a contract with a sub-distributor for dental and veterinary markets in Australia, New Zealand and Tasmania. The sub- distributor currently has access to over 15,000 dentists, of which 80% are in the private sector. The Company expects to receive initial stocking orders shortly.

Additionally, the Company is expanding its distribution into India and Mexico through exclusive agreements with distributors in these countries. Both agreements include yearly purchase requirements.

New Product Line

The Company will introduce its HemoStrip™ adhesive bandage to the retail markets in the second quarter of 2015. HemoStrip™, the ultimate bandage, contains the Company's proprietary HemoStyp® gauze on an adhesive strip, which has been designed to achieve rapid hemostasis in a cut or abrasion. Initial interest in HemoStrip™ has been positive during discussions with major retailers. 

Swine Test

Preliminary positive results from the swine testing performed at Spring Valley Laboratories, a GLP compliant CRO laboratory, have been received. The tests were performed on pigs where the femoral arteries were exposed. A 5 millimeter puncture wound was created under extreme pressure and preliminary results show complete hemostasis was achieved with the HemoStyp® gauze in substantially less time than competitive products. The final results will be published in the near future. 

Corporate News

On October 2nd, 2014, the Company received formal notice that the settlement of the civil case pending in the State of Nevada had been recorded. The settlement includes the retirement of debt in the form of notes in excess of $500,000 and the return of approximately 1,000,000 shares of the common stock of the Company.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

PCG Advisory Group, LLC
Scott Powell, Managing Director
Tel: +1-646-780-8850
Email: spowell@pcgadvisory.com
www.pcgadvisory.com

United Health Products INC. Receives Initial Medicom® Order

Henderson, NV – October 21, 2014 – United Health Products Inc. (OTCQB: UEEC) announced that its Canadian distributor Medicom® has placed an initial sampling and stocking order for the US and Canadian Dental Markets.  Medicom®, headquartered in Montreal, Quebec with operations in over 50 countries, is a globally recognized manufacturer and supplier to the Dental and Health Care Industries.

Military Protocol Swine test

United Health Products Inc. will be conducting a series of tests next week at Spring Valley Laboratories, a military approved GLP compliant CRO research facility. The purpose of the tests is to evaluate the efficacy of HemoStyp® Trauma Gauze in an uncontrolled hemorrhage environment. The test will be performed on swine to simulate wounds associated with battle and injuries sustained from accidents. Representatives from various agencies including the US Military have been invited to attend. The results and findings of the test will be presented in a white paper and published.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

About Medicom®

Medicom® is a private Canadian company founded by Ronald Reuben in 1988. Medicom® is a global health care company headquartered in Montreal, Quebec with operations in over 50 countries, including Canada, the United States, the Netherlands, France, China and Taiwan. Ronald Reuben, Founder and Chief Executive Officer, was the winner of the world’s most prestigious business award for entrepreneurs, EY Entrepreneur of the Year in 2013 award in the Science category for Quebec. www.medicom.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

PCG Advisory Group, LLC
Scott Powell, Managing Director
Tel: +1-646-780-8850
Email: spowell@pcgadvisory.com
www.pcgadvisory.com